Back to Search
MARK SHLOMCHIK, MD
MD
Clinical Pathology/Laboratory Medicine Physician
NPI: 1992796387Individual
Specialties, Licenses & Credentials
Clinical Pathology/Laboratory Medicine PhysicianPrimary
Pathology — Clinical Pathology/Laboratory Medicine
Code: 207ZP0105X
032870(CT)
Research & Publications (20)
Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice.
PMID 19265127·J Immunol·2009
7-preclinical
Sites and stages of autoreactive B cell activation and regulation.
PMID 18199415·Immunity·2008
6-review
Activation of rheumatoid factor (RF) B cells and somatic hypermutation outside of germinal centers in autoimmune-prone MRL/lpr mice.
PMID 12727622·Ann N Y Acad Sci·2003
6-review
The role of antibodies and B cells in the pathogenesis of lupus nephritis.
PMID 12778333·Springer Semin Immunopathol·2003
6-review
From T to B and back again: positive feedback in systemic autoimmune disease.
PMID 11905822·Nat Rev Immunol·2001
6-review
Neuroinvasion by a Creutzfeldt-Jakob disease agent in the absence of B cells and follicular dendritic cells.
PMID 11470899·Proc Natl Acad Sci U S A·2001
7-preclinical
Langerhans cell deficiency impairs Ixodes scapularis suppression of Th1 responses in mice.
PMID 19273564·Infect Immun·2009
7-preclinical
Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop.
PMID 19587008·J Immunol·2009
7-preclinical
Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge.
PMID 19251656·Proc Natl Acad Sci U S A·2009
7-preclinical
Expression of diabetes-associated genes by dendritic cells and CD4 T cells drives the loss of tolerance in nonobese diabetic mice.
PMID 19592648·J Immunol·2009
7-preclinical
BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact.
PMID 18832171·Proc Natl Acad Sci U S A·2008
7-preclinical
Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha.
PMID 18941176·J Immunol·2008
4-observational
T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells.
PMID 18691914·Immunity·2008
7-preclinical
Maintenance of the plasma cell pool is independent of memory B cells.
PMID 18339801·Proc Natl Acad Sci U S A·2008
7-preclinical
In situ identification of allospecific B cells using pentamers.
PMID 18362221·Blood·2008
7-preclinical
Improved methods for detecting selection by mutation analysis of Ig V region sequences.
PMID 18397909·Int Immunol·2008
7-preclinical
Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities.
PMID 18566367·J Immunol·2008
4-observational
Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation.
PMID 18583569·Blood·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 20 YORK ST, YNHH, CLINIC BUILDING, ROOM 407
NEW HAVEN, CT 06510 - Phone
- (203) 785-2153
Quick Facts
- NPI
- 1992796387
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile